A human homologue of the Drosophila Toll protein signals activation of adaptive immunity - PubMed (original) (raw)
. 1997 Jul 24;388(6640):394-7.
doi: 10.1038/41131.
Affiliations
- PMID: 9237759
- DOI: 10.1038/41131
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
R Medzhitov et al. Nature. 1997.
Abstract
Induction of the adaptive immune response depends on the expression of co-stimulatory molecules and cytokines by antigen-presenting cells. The mechanisms that control the initial induction of these signals upon infection are poorly understood. It has been proposed that their expression is controlled by the non-clonal, or innate, component of immunity that preceded in evolution the development of an adaptive immune system in vertebrates. We report here the cloning and characterization of a human homologue of the Drosophila toll protein (Toll) which has been shown to induce the innate immune response in adult Drosophila. Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor. Both Drosophila Toll and the IL-1 receptor are known to signal through the NF-kappaB pathway. We show that a constitutively active mutant of human Toll transfected into human cell lines can induce the activation of NF-kappaB and the expression of NF-kappaB-controlled genes for the inflammatory cytokines IL-1, IL-6 and IL-8, as well as the expression of the co-stimulatory molecule B7.1, which is required for the activation of naive T cells.
Comment in
- Seeking wisdom in innate immunity.
Fearon DT. Fearon DT. Nature. 1997 Jul 24;388(6640):323-4. doi: 10.1038/40967. Nature. 1997. PMID: 9237746 No abstract available.
Similar articles
- Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans.
Chaudhary PM, Ferguson C, Nguyen V, Nguyen O, Massa HF, Eby M, Jasmin A, Trask BJ, Hood L, Nelson PS. Chaudhary PM, et al. Blood. 1998 Jun 1;91(11):4020-7. Blood. 1998. PMID: 9596645 - The Toll-receptor family and control of innate immunity.
Kopp EB, Medzhitov R. Kopp EB, et al. Curr Opin Immunol. 1999 Feb;11(1):13-8. doi: 10.1016/s0952-7915(99)80003-x. Curr Opin Immunol. 1999. PMID: 10047546 Review. - Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA. Fitzgerald KA, et al. Nature. 2001 Sep 6;413(6851):78-83. doi: 10.1038/35092578. Nature. 2001. PMID: 11544529 - TLR6: A novel member of an expanding toll-like receptor family.
Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, Jenkins NA, Takeda K, Akira S. Takeuchi O, et al. Gene. 1999 Apr 29;231(1-2):59-65. doi: 10.1016/s0378-1119(99)00098-0. Gene. 1999. PMID: 10231569 - Toll receptors: an expanding role in our understanding of human disease.
Schuster JM, Nelson PS. Schuster JM, et al. J Leukoc Biol. 2000 Jun;67(6):767-73. J Leukoc Biol. 2000. PMID: 10857847 Review.
Cited by
- SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
Wang W, Zhou Z, Xiao X, Tian Z, Dong X, Wang C, Li L, Ren L, Lei X, Xiang Z, Wang J. Wang W, et al. Cell Mol Immunol. 2021 Apr;18(4):945-953. doi: 10.1038/s41423-020-00619-y. Epub 2021 Feb 26. Cell Mol Immunol. 2021. PMID: 33637958 Free PMC article. - Molecular cloning and characterization of Toll-like receptor 3, and inductive expression analysis of type I IFN, Mx and pro-inflammatory cytokines in the Indian carp, rohu (Labeo rohita).
Samanta M, Basu M, Swain B, Panda P, Jayasankar P. Samanta M, et al. Mol Biol Rep. 2013 Jan;40(1):225-35. doi: 10.1007/s11033-012-2053-6. Epub 2012 Oct 12. Mol Biol Rep. 2013. PMID: 23065215 - N-acetyldopamine dimer inhibits neuroinflammation through the TLR4/NF-κB and NLRP3/Caspase-1 pathways.
Huang L, Gong L, Huo X, Lei L, Zhang Q, Hu Y, Kuang Q, Gui Y, Dai Y, Gu Y, Deng Y, Wang D, Guo D. Huang L, et al. Acta Biochim Biophys Sin (Shanghai). 2022 Aug 25;55(1):23-33. doi: 10.3724/abbs.2022116. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 36017888 Free PMC article. - Insight into the beneficial immunomodulatory mechanism of the sevoflurane metabolite hexafluoro-2-propanol in a rat model of endotoxaemia.
Urner M, Schläpfer M, Herrmann IK, Hasler M, Schimmer RR, Booy C, Roth Z'graggen B, Rehrauer H, Aigner F, Minshall RD, Stark WJ, Beck-Schimmer B. Urner M, et al. Clin Exp Immunol. 2015 Sep;181(3):468-79. doi: 10.1111/cei.12648. Epub 2015 Jul 7. Clin Exp Immunol. 2015. PMID: 25925908 Free PMC article. - Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvants.
Shanmugam A, Rajoria S, George AL, Mittelman A, Suriano R, Tiwari RK. Shanmugam A, et al. PLoS One. 2012;7(2):e30839. doi: 10.1371/journal.pone.0030839. Epub 2012 Feb 20. PLoS One. 2012. PMID: 22363498 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases